Radiation therapy combined with tyrosine kinase inhibitors in 826 patients with HER2-positive breast cancer brain metastases: a systematic review and network meta-analysis | Synapse
March 3, 2026
Radiation therapy combined with tyrosine kinase inhibitors in 826 patients with HER2-positive breast cancer brain metastases: a systematic review and network meta-analysis
Key Points
This combined treatment approach shows significant improvement in managing brain metastases for HER2-positive breast cancer.
Key evidence indicates a notable reduction in disease progression when utilizing this combination, enhancing patient outcomes.
Systematic review and network meta-analysis highlight effectiveness across multiple studies, providing a robust overview of treatment efficacy.
This strategy may enable better treatment protocols but requires further validation in larger cohorts to fully understand its impact.